Brian Becknell

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody

Don M. Benson, Courtney E. Bakan, Anjali Mishra et al. · Blood · 2010 · 797 citations · Full text

Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.

Susan P. Whitman, Kellie J. Archer, Feng Lin et al. · PubMed · 2001 · 638 citations

Hematological Malignancy, Flt3 Gene, Medicine +13

Phosphorylation and Inactivation of BAD by Mitochondria-Anchored Protein Kinase A

Hisashi Harada, Brian Becknell, Matthias Wilm et al. · Molecular Cell · 1999 · 633 citations · Full text

Mitophagy, Signal Transduction, Mitochondrial Function +8

Evidence for discrete stages of human natural killer cell differentiation in vivo

Aharon G. Freud, Akihiko Yokohama, Brian Becknell et al. · The Journal of Experimental Medicine · 2006 · 425 citations · Full text

Nk Cell Differentiation, Human Cell, Cell Specialization +13

A Human CD34(+) Subset Resides in Lymph Nodes and Differentiates into CD56brightNatural Killer Cells

Aharon G. Freud, Brian Becknell, Sameek Roychowdhury et al. · Immunity · 2005 · 378 citations · Full text

Subset Resides, Human Cd34, Lymphocyte Development +9